SAINT ANTHONY – The first round of people participating in a COVID-19 vaccine trial in South Texas received a dose Thursday.
The double-blind Pfizer trial is different from that of Moderna, which is undergoing a vaccine trial, which begins on Friday after being delayed a few days.
“I can’t think of a more important clinical trial than participating in it, as this is the biggest health threat to my life,” said Dr. Steven Davis, one of the first participants in the Pfizer trial. ”I am a big believer in clinical trials. We, in my own practice, do clinical trials. And if it weren̵7;t for clinical trials, we wouldn’t have things like the polio vaccine. “
Although the trial is a double-blind study and Davis is not sure whether he, his wife or his son will be given the real vaccine or placebo, he said he is happy to receive the opportunity to join in.
“They want to test people over the age of 65. Both my wife and I are over 65 years old. They want to test people who are directly involved in health care. Both me and my son, who work in my office, are directly involved in health care, ”Davis said.
Texas biotechnology facilities at College Station took advantage to mass-produce the potential COVID-19 vaccine
To participate in the Pfizer trial, you must be about 18 years old and call the clinical trials in Texas, the lab that hosts the study, to get it.
“We want to know and try to determine … If they have any disease or any disease, is it under control? We want to know what drugs are being used,” said CTT CEO Kay Scroggins.
Like the other trials, the researchers assure participants that they cannot become infected with the coronavirus by receiving the Pfizer vaccine, which is not live.
“It’s a particle of the virus. And so, when the virus is administered, we get an immune response,” Scroggins said.
If the trial is successful and everything goes as planned, the Pfizer vaccine could be available to the public from the beginning of next year.
UK scientists immunize hundreds of coronavirus vaccines
Texas clinical trials aim to analyze thousands more people to participate in the two-year Pfizer study, as well as at least two other COVID-19 vaccination studies that are expected to begin in the coming months.
For more information call 210-949-0122 or click here.
Copyright 2020 KSAT – All rights reserved.